Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
PCRX on Nasdaq
Shares outstanding
42,998,448
Price per share
$20.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
46,913,762
Total reported value
$1,214,112,730
% of total 13F portfolios
0%
Share change
-1,013,163
Value change
-$26,116,678
Number of holders
257
Price from insider filings
$20.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $189,462,213 7,017,119 BlackRock, Inc. 31 Mar 2025
Doma Perpetual Capital Management LLC 6.8% 0% $67,693,102 2,936,794 0% Doma Perpetual Capital Management LLC 30 Dec 2025
RENAISSANCE TECHNOLOGIES LLC 5% -7.2% $55,101,440 -$6,633,198 2,138,201 -11% Renaissance Technologies LLC 01 Jul 2025
Pacer Advisors, Inc. 1.3% -81% $16,245,036 -$71,851,563 601,668 -82% Pacer Advisors, Inc. 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 0.7% -88% $9,331,875 -$53,804,088 345,625 -85% Millennium Management LLC 31 Mar 2025

As of 31 Dec 2025, 257 institutional investors reported holding 46,913,762 shares of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX). This represents 109% of the company’s total 42,998,448 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 7,064,280 -3.7% 0% $182,823,565
VANGUARD GROUP INC 11% 4,812,955 -7.4% 0% $124,559,276
Doma Perpetual Capital Management LLC 6.5% 2,777,794 +2.8% 20% $71,889,309
D. E. Shaw & Co., Inc. 4.7% 2,039,927 +5% 0.04% $52,793,311
DIMENSIONAL FUND ADVISORS LP 4.5% 1,950,013 -9.9% 0.01% $50,466,985
RENAISSANCE TECHNOLOGIES LLC 4.4% 1,884,001 -12% 0.08% $48,757,946
STATE STREET CORP 4.4% 1,883,367 -0.9% 0% $48,741,538
AMERICAN CENTURY COMPANIES INC 3.1% 1,336,047 -3.1% 0.02% $34,576,897
GOLDMAN SACHS GROUP INC 3% 1,300,387 -0.73% 0% $33,654,016
MORGAN STANLEY 2.8% 1,192,594 +4.4% 0% $30,864,360
GEODE CAPITAL MANAGEMENT, LLC 2.7% 1,169,591 -3.8% 0% $30,273,503
Balyasny Asset Management L.P. 2.2% 945,979 -50% 0.05% $24,481,937
CITADEL ADVISORS LLC 1.9% 819,768 +1052% 0.01% $21,215,596
Impax Asset Management Group plc 1.7% 750,027 +25% 0.12% $19,410,699
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.6% 676,352 +7.8% 0% $17,503,990
UBS Group AG 1.3% 558,651 -35% 0% $14,457,888
NORTHERN TRUST CORP 1.2% 528,483 -8% 0% $13,677,140
WELLINGTON MANAGEMENT GROUP LLP 1.2% 518,537 -1.9% 0% $13,419,737
GAGNON SECURITIES LLC 1.2% 501,211 +11% 2.6% $12,971,341
TWO SIGMA INVESTMENTS, LP 1.1% 451,852 +94% 0.02% $11,693,930
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1% 441,205 -0.79% 0.24% $11,418,385
J. Goldman & Co LP 1% 437,253 -35% 0.44% $11,316,108
Assenagon Asset Management S.A. 1% 435,143 +87% 0.02% $11,261,501
DEUTSCHE BANK AG\ 0.9% 387,540 +0.42% 0% $10,029,536
JANE STREET GROUP, LLC 0.9% 385,984 +163% 0.01% $9,989,265

Institutional Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 46,913,762 $1,214,112,730 -$26,116,678 $25.88 257
2025 Q3 47,959,507 $1,235,859,061 -$66,264,911 $25.77 236
2025 Q2 50,544,394 $1,207,981,451 -$359,554 $23.90 230
2025 Q1 50,618,298 $1,257,877,040 +$32,555,405 $24.85 234
2024 Q4 49,919,979 $940,563,254 -$16,965,371 $18.84 229
2024 Q3 51,260,756 $771,636,682 -$165,775,978 $15.05 235
2024 Q2 51,907,448 $1,485,006,047 +$74,680,393 $28.61 274
2024 Q1 49,148,207 $1,436,043,998 +$18,739,360 $29.22 267
2023 Q4 48,345,728 $1,631,093,080 -$9,894,207 $33.74 257
2023 Q3 47,455,861 $1,455,850,736 -$4,481,511 $30.68 257
2023 Q2 46,990,206 $1,882,388,532 +$21,451,347 $40.07 253
2023 Q1 46,385,914 $1,892,433,173 -$75,486,559 $40.81 265
2022 Q4 48,634,371 $1,878,207,869 -$89,054,242 $38.61 268
2022 Q3 50,521,839 $2,687,327,030 +$59,266,186 $53.19 258
2022 Q2 48,969,306 $2,854,741,313 -$35,627,879 $58.30 271
2022 Q1 49,630,099 $3,785,465,240 -$42,659,805 $76.32 288
2021 Q4 50,609,311 $3,045,397,753 +$82,990,546 $60.17 264
2021 Q3 49,136,451 $2,751,568,452 -$7,655,613 $56.00 252
2021 Q2 49,208,257 $2,985,423,936 -$36,503,493 $60.68 254
2021 Q1 49,838,933 $3,492,801,331 -$28,991,250 $70.09 265
2020 Q4 50,361,027 $3,013,925,217 +$130,605,627 $59.84 257
2020 Q3 48,261,472 $2,900,663,579 -$13,442,917 $60.12 255
2020 Q2 48,714,511 $2,556,091,692 +$106,862,036 $52.47 241
2020 Q1 47,013,757 $1,575,389,148 +$37,748,644 $33.53 216
2019 Q4 45,473,669 $2,059,876,910 +$15,602,991 $45.30 227
2019 Q3 45,127,604 $1,719,636,471 +$75,354,132 $38.07 206
2019 Q2 42,785,132 $1,860,642,605 +$104,977,686 $43.49 216
2019 Q1 41,311,639 $1,572,292,288 +$29,425,330 $38.06 203
2018 Q4 40,070,574 $1,723,815,270 -$34,296,780 $43.02 201
2018 Q3 40,623,085 $1,996,511,486 -$82,329,285 $49.15 182
2018 Q2 42,889,912 $1,372,185,151 -$17,981,461 $32.05 148
2018 Q1 43,600,469 $1,358,176,862 +$18,671,408 $31.15 163
2017 Q4 41,893,801 $1,912,243,195 -$62,679,837 $45.65 180
2017 Q3 43,743,311 $1,644,050,296 +$59,542,040 $37.55 176
2017 Q2 41,206,727 $1,966,090,329 +$10,414,759 $47.70 191
2017 Q1 40,931,045 $1,867,446,801 +$210,949,898 $45.60 187
2016 Q4 40,261,661 $1,300,363,433 +$16,595,121 $32.30 178
2016 Q3 39,781,555 $1,361,150,206 -$42,541,112 $34.22 176
2016 Q2 40,740,565 $1,374,319,414 -$218,609,357 $33.73 180
2016 Q1 43,548,971 $2,306,969,256 -$41,725,115 $52.98 178
2015 Q4 42,594,333 $3,270,958,952 +$18,283,931 $76.79 211
2015 Q3 42,828,994 $1,760,421,594 -$32,382,597 $41.10 175
2015 Q2 42,812,775 $3,027,024,743 +$138,370,309 $70.72 186
2015 Q1 40,352,606 $3,586,390,141 +$93,129,534 $88.85 205
2014 Q4 39,199,914 $3,476,202,536 +$20,871,375 $88.66 198
2014 Q3 38,686,756 $3,749,136,189 +$100,496,443 $96.92 205
2014 Q2 37,779,749 $3,470,023,168 +$237,465,957 $91.86 190
2014 Q1 35,265,656 $2,468,133,086 +$14,361,551 $69.99 160